← SynDRA
BRD-K52640952
SynDRA canonical compound SYN0086954 — structure-anchored drug synonym record
| Primary target(s) | PLA2G1B |
|---|
| Mechanism of action | Topoisomerase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALOX15
- APOBEC3G
- TSHR
- TP53
- THPO
- STAT6
- SMAD3
- S100A4
- RAPGEF4
- RAPGEF3
- PTH1R
- PAX8
- NR1H2
- NFKB1
- MAPK1
- HIF1A
- HBB
- GLP1R
- CYP3A4
- CYP2D6
- CYP2C9
- CYP2C19
- CYP1A2
- BRCA1
- BLM
- WRN
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACM1
- MLLT3
- TR10B
- TPO
- TAAR1
- SIAE
- S10A4
- RGS12
- PRMT1
- MDR1
- ACM4
- MBD2
- MAPT
- GNAI1
- CP1A2
- COT2
- CFTR
- ACM5
- UHRF1
Cross-references
Synonyms
- (2R)-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydrochromen-4-one
- (S)-2,3-Dihydro-5-hydroxy-7-methoxy-2-phenyl-4-benzopyrone
- MEGxp0_001269
- ACon1_000237
- CHEBI:94054
- NCGC00180751-01
- BRD-K52640952-001-01-1
Look up BRD-K52640952 in the interactive SynDRA portal →